Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 281.5 TWD -1.4% Market Closed
Market Cap: 74.7B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Lotus Pharmaceutical Co Ltd

Current Assets 13.7B
Cash & Short-Term Investments 3.1B
Receivables 6.4B
Other Current Assets 4.3B
Non-Current Assets 20.6B
Long-Term Investments 3.1B
PP&E 3.6B
Intangibles 13.1B
Other Non-Current Assets 756m
Current Liabilities 6B
Accounts Payable 696.9m
Short-Term Debt 557.5m
Other Current Liabilities 4.8B
Non-Current Liabilities 11.1B
Long-Term Debt 9.6B
Other Non-Current Liabilities 1.5B

Balance Sheet
Lotus Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: TWD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 096
1 578
2 015
1 774
1 023
1 277
38
29
24
1 771
Cash
1 096
1 046
0
1 774
1 023
1 277
0
0
0
1 771
Cash Equivalents
0
532
2 015
0
0
0
38
29
24
0
Short-Term Investments
74
50
25
0
0
0
0
0
0
0
Total Receivables
0
0
1 377
1 409
1 214
2 417
2 801
3 407
4 927
6 617
Accounts Receivables
0
0
1 187
1 244
1 130
2 243
2 736
3 257
4 651
6 384
Other Receivables
0
0
190
165
84
175
65
150
276
233
Inventory
0
0
971
923
1 161
1 343
2 208
3 073
3 330
3 775
Other Current Assets
0
0
80
100
162
684
285
247
420
489
Total Current Assets
0
0
4 469
4 206
3 560
5 721
6 783
8 333
10 661
12 653
PP&E Net
0
0
1 954
1 885
1 815
2 049
2 305
2 642
3 148
3 511
PP&E Gross
0
0
1 954
1 885
1 815
2 049
2 305
2 642
3 148
3 511
Accumulated Depreciation
0
0
869
1 128
1 268
1 367
1 492
1 682
1 868
2 035
Intangible Assets
0
0
1 880
2 379
2 185
2 911
3 831
3 863
7 315
7 365
Goodwill
0
0
6 009
6 130
6 083
5 910
5 896
5 586
5 668
5 670
Note Receivable
0
0
0
0
0
0
0
0
0
153
Long-Term Investments
0
0
20
11
9
458
413
302
2 158
3 048
Other Long-Term Assets
0
0
912
1 024
1 201
1 146
526
496
575
592
Other Assets
0
0
6 009
6 130
6 083
5 910
5 896
5 586
5 668
5 670
Total Assets
0
N/A
0
N/A
15 244
N/A
15 636
+3%
14 854
-5%
18 195
+22%
19 753
+9%
21 222
+7%
29 526
+39%
32 992
+12%
Liabilities
Accounts Payable
0
0
468
417
728
935
1 732
748
1 403
671
Short-Term Debt
0
0
360
260
310
460
410
820
156
510
Current Portion of Long-Term Debt
0
0
1 384
205
300
638
1 400
857
119
1 373
Other Current Liabilities
0
0
1 024
1 015
766
1 068
1 342
1 901
4 215
1 970
Total Current Liabilities
0
0
3 235
1 897
2 104
3 101
4 883
4 326
5 893
4 524
Long-Term Debt
0
0
2 714
4 411
1 462
3 840
5 024
4 710
8 643
9 702
Deferred Income Tax
0
0
252
245
197
172
145
304
448
721
Minority Interest
0
0
926
409
455
24
0
0
0
0
Other Liabilities
0
0
682
1 429
3 411
3 364
956
813
674
711
Total Liabilities
0
N/A
0
N/A
7 809
N/A
8 390
+7%
7 628
-9%
10 453
+37%
11 008
+5%
10 153
-8%
15 658
+54%
15 658
0%
Equity
Common Stock
0
0
2 385
2 385
2 382
2 431
2 454
2 628
2 626
2 650
Retained Earnings
0
0
798
1 027
995
653
354
1 701
4 823
8 900
Additional Paid In Capital
0
0
6 154
6 021
6 021
6 588
6 799
8 039
7 534
7 131
Unrealized Security Profit/Loss
0
0
0
1
0
170
203
269
272
82
Treasury Stock
0
23
23
23
0
0
0
58
57
51
Other Equity
0
0
283
109
182
454
658
972
786
1 214
Total Equity
0
N/A
0
N/A
7 435
N/A
7 246
-3%
7 226
0%
7 742
+7%
8 745
+13%
11 069
+27%
13 868
+25%
17 334
+25%
Total Liabilities & Equity
0
N/A
0
N/A
15 244
N/A
15 636
+3%
14 854
-5%
18 195
+22%
19 753
+9%
21 222
+7%
29 526
+39%
32 992
+12%
Shares Outstanding
Common Shares Outstanding
0
0
238
238
238
243
245
262
262
264

See Also

Discover More